While the molecular events by which altered TREX1 function causes SVD is unknown, increasing lines of evidence suggest an association with activated innate immunity, including pathways that are potentially amenable to therapeutic intervention11,22. This evidence concerns the gene TREX1 and snowflake vitreoretinal degeneration.